AR048193A1 - Procedimiento para la preparacion de una composicion secada por pulverizacion que comprende talnetant, composicion farmaceutica obtenida segun dicho procedimiento y forma de dosificacion que comprende la mencionada composicion - Google Patents

Procedimiento para la preparacion de una composicion secada por pulverizacion que comprende talnetant, composicion farmaceutica obtenida segun dicho procedimiento y forma de dosificacion que comprende la mencionada composicion

Info

Publication number
AR048193A1
AR048193A1 ARP050101190A ARP050101190A AR048193A1 AR 048193 A1 AR048193 A1 AR 048193A1 AR P050101190 A ARP050101190 A AR P050101190A AR P050101190 A ARP050101190 A AR P050101190A AR 048193 A1 AR048193 A1 AR 048193A1
Authority
AR
Argentina
Prior art keywords
procedure
composition
talnetant
preparation
dosage
Prior art date
Application number
ARP050101190A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR048193A1 publication Critical patent/AR048193A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un procedimiento para la preparacion de una composicion secada por pulverizacion, comprendiendo la composicion i) partículas de talnetant que tienen un Dv90 en el intervalo de 0,1 a 2,0 (mu)m, ii) uno o varios tensioactivos ionicos e iii) uno o varios vehículos solubles, comprendiendo el procedimiento a) moles en humedo una dispersion de partículas solidas de talnetant hasta un Dv90 que esté en el intervalo de 0,1 a 2,0 (mu)m, cuya dispersion comprende uno o varios tensioactivos ionicos y uno o varios vehículos solubles, después b) secar por pulverizacion o granular por pulverizacion la dispersion resultante. El talnetant es un antagonista de receptor de NK3 y las composiciones así obtenidas tienen mayor biodisponibilidad. Composicion farmacéutica obtenida mediante dicho procedimiento y forma de dosificacion que comprende esta ultima.
ARP050101190A 2004-03-30 2005-03-28 Procedimiento para la preparacion de una composicion secada por pulverizacion que comprende talnetant, composicion farmaceutica obtenida segun dicho procedimiento y forma de dosificacion que comprende la mencionada composicion AR048193A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55757104P 2004-03-30 2004-03-30

Publications (1)

Publication Number Publication Date
AR048193A1 true AR048193A1 (es) 2006-04-05

Family

ID=34956393

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101190A AR048193A1 (es) 2004-03-30 2005-03-28 Procedimiento para la preparacion de una composicion secada por pulverizacion que comprende talnetant, composicion farmaceutica obtenida segun dicho procedimiento y forma de dosificacion que comprende la mencionada composicion

Country Status (27)

Country Link
US (1) US20070178151A1 (es)
EP (1) EP1729734B1 (es)
JP (1) JP2007530702A (es)
KR (1) KR20060135000A (es)
CN (1) CN1933816A (es)
AR (1) AR048193A1 (es)
AT (1) ATE387189T1 (es)
AU (1) AU2005231355B2 (es)
BR (1) BRPI0508111A (es)
CA (1) CA2556461A1 (es)
DE (1) DE602005005033T2 (es)
DK (1) DK1729734T3 (es)
ES (1) ES2301003T3 (es)
HK (1) HK1099213A1 (es)
HR (1) HRP20080154T3 (es)
IL (1) IL177606A0 (es)
IS (1) IS8548A (es)
MA (1) MA28557B1 (es)
NO (1) NO20064864L (es)
NZ (1) NZ549096A (es)
PE (1) PE20060161A1 (es)
PL (1) PL1729734T3 (es)
PT (1) PT1729734E (es)
RU (1) RU2006138054A (es)
TW (1) TW200602055A (es)
WO (1) WO2005097077A2 (es)
ZA (1) ZA200606670B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506800D0 (en) * 2005-04-04 2005-05-11 Merck Sharp & Dohme New uses
TW200803854A (en) * 2005-09-30 2008-01-16 Smithkline Beecham Corp Pharmaceutical compositions
EP1940357A2 (en) * 2005-09-30 2008-07-09 SmithKline Beecham Corporation Pharmaceutical compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
ES2227769T3 (es) * 1994-05-27 2005-04-01 Glaxosmithkline S.P.A. Derivados de quinolina como antagonistas del receptor nk3 de taquiquinina.
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
DE19501269A1 (de) * 1995-01-18 1996-07-25 Henkel Kgaa Amorphes Alkalisilikat-Compound
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
ATE367802T1 (de) * 2000-09-20 2007-08-15 Jagotec Ag Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
MY134211A (en) * 2001-05-18 2007-11-30 Smithkline Beecham Corp Novel use
ATE371442T1 (de) * 2001-10-12 2007-09-15 Elan Pharma Int Ltd Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung

Also Published As

Publication number Publication date
DE602005005033T2 (de) 2009-03-19
MA28557B1 (fr) 2007-04-03
WO2005097077A2 (en) 2005-10-20
EP1729734A2 (en) 2006-12-13
AU2005231355B2 (en) 2008-09-18
ES2301003T3 (es) 2008-06-16
AU2005231355A1 (en) 2005-10-20
IS8548A (is) 2006-10-06
DK1729734T3 (da) 2008-06-16
CN1933816A (zh) 2007-03-21
NO20064864L (no) 2006-10-25
RU2006138054A (ru) 2008-05-10
ATE387189T1 (de) 2008-03-15
EP1729734B1 (en) 2008-02-27
NZ549096A (en) 2009-05-31
CA2556461A1 (en) 2005-10-20
BRPI0508111A (pt) 2007-07-17
DE602005005033D1 (de) 2008-04-10
WO2005097077A3 (en) 2006-04-13
HK1099213A1 (en) 2007-08-10
KR20060135000A (ko) 2006-12-28
ZA200606670B (en) 2008-01-30
TW200602055A (en) 2006-01-16
JP2007530702A (ja) 2007-11-01
US20070178151A1 (en) 2007-08-02
HRP20080154T3 (en) 2008-10-31
PL1729734T3 (pl) 2008-09-30
PT1729734E (pt) 2008-05-29
IL177606A0 (en) 2006-12-10
PE20060161A1 (es) 2006-05-10

Similar Documents

Publication Publication Date Title
HRP20050280A2 (en) Solid pharmaceutical formulations comprising telmisartan
CR9292A (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
SG170087A1 (en) Pharmaceutical compositions
HRP20191299T1 (hr) Formulacije protutijela
WO2009100441A3 (en) Depot formulations
CL2007002336A1 (es) Composicion que tiene particulas que comprende elementos inorganicos, uno o mas ingredientes activos y opcionalmente, agentes moduladores de la tasa de liberacion; procedimiento para prepararla; las particulas, util para la entrega de ingredientes ac
HN2008000646A (es) Antagonistas de los receptores 2 de dopamina de rapida disociacion
CL2007003081A1 (es) Compuestos derivados de acido tetramico sustituidos con trifluorometoxi-fenilo; procedimiento para la preparacion de dichos compuestos; agentes para combatir plagas y/o vegetaciones indeseadas; uso de dichos compuestos; procedimiento para preparar ag
HRP20120121T1 (hr) Tabletiranje eritritola
CL2007003266A1 (es) Compuestos derivados de progesterona, antagonistas del receptor de progesterona; composicion farmaceutica; y uso para el tratamiento de endometriosis, miomas o tumores dependientes de hormonas.
WO2007011878A8 (en) Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
AR048193A1 (es) Procedimiento para la preparacion de una composicion secada por pulverizacion que comprende talnetant, composicion farmaceutica obtenida segun dicho procedimiento y forma de dosificacion que comprende la mencionada composicion
EA201491675A1 (ru) Новые вещества
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
RS54329B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
BRPI0509194A (pt) formulação e método de comprimido revestido
CY1113175T1 (el) Ενωση σουλφοναμιδης και εφαρμογη αυτης
EA201001312A1 (ru) Твердая фармацевтическая композиция, содержащая непептидный антагонист рецептора ангиотензина ii и диуретик
DE602007004306D1 (de) Waschmittelszusammensetzung mit verkapseltem flüssigem pflegemittel
HRP20100216T1 (hr) Kruti farmaceutski pripravak koji sadrži irbesartan
HRP20120134T1 (hr) Stabilni i lako topivljivi pripravci kandesartan-cileksetila, dobiveni vlažnim granuliranjem
CL2007003556A1 (es) Compuestos derivados de 6-(piperidin-4-ilamino)piridazin-3-carbonitrilos, antagonistas del receptor de dopamina 2 de rapida disociacion; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el
WO2007044251A3 (en) Pharmaceutical compositions
ATE402706T1 (de) Im mund zerfallende pharmazeutische zusammensetzung mit risperidon
WO2010006200A3 (en) Triggered release of drugs from polymer particles

Legal Events

Date Code Title Description
FA Abandonment or withdrawal